Histone deacetylase inhibitors for epigenetic therapy of cancer
- 1 April 2007
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Anti-Cancer Drugs
- Vol. 18 (4), 363-370
- https://doi.org/10.1097/cad.0b013e328012a5db
Abstract
Histone acetylation and histone deacetylation play key roles in the epigenetic regulation. Thus, inhibition of deacetylation controlled by histone deacetylases may result in chromatin remodeling, upregulation of key tumor repressor genes, differentiation or apoptosis. Therefore many naturally occurring and synthetic histone deacetylase inhibitors have been shown to display potent anticancer activities in preclinical studies. The exact mechanism by which histone deacetylases exert their effect, however, is still obscure; in any case it is more complicated than originally understood. Although several representatives of this novel class of therapeutic agents are currently at early stages of clinical development, rational design leading to highly selective histone deacetylase inhibitors against histone deacetylase isoforms will not only probably offer more potent anticancer drugs, but also critical insights into their mechanism of action.Keywords
This publication has 86 references indexed in Scilit:
- HDAC Inhibitors and Cardiac SafetyClinical Cancer Research, 2007
- HDAC3 is crucial in shear- and VEGF-induced stem cell differentiation toward endothelial cellsThe Journal of cell biology, 2006
- Anticancer activities of histone deacetylase inhibitorsNature Reviews Drug Discovery, 2006
- Cardiac Studies in Patients Treated with Depsipeptide, FK228, in a Phase II Trial for T-Cell LymphomaClinical Cancer Research, 2006
- Epigenetic therapy of cancer: past, present and futureNature Reviews Drug Discovery, 2006
- Discovery of pyrimidyl-5-hydroxamic acids as new potent histone deacetylase inhibitorsEuropean Journal of Medicinal Chemistry, 2005
- Epigenetics in human disease and prospects for epigenetic therapyNature, 2004
- Efficacy of dinaline and its methyl and acetyl derivatives against colorectal cancer in vivo and in vitroEuropean Journal of Cancer, 1996
- Derivatives of butyric acid as potential anti‐neoplastic agentsInternational Journal of Cancer, 1991
- Butyric acid: A small fatty acid with diverse biological functionsLife Sciences, 1980